astragaloside a has been researched along with Chronic Disease in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, W; Fan, X; Gao, S; Huang, C; Jiao, G; Qiu, S; Sun, M; Tao, X; Weng, N; Zhang, F; Zhou, X | 1 |
| Tan, HY; Tang, B; Wei, XQ; Zhang, JG | 1 |
| Cho, Y; Cho, YD; Chung, DY; Hong, EK; Kang, IH; Kim, JS; Kim, S; Kim, SH; Nam, JB; Shin, JW; Sohn, NW | 1 |
| Chen, Z; Du, Q; Huang, M; Yin, KS; Zhang, Q; Zhou, LF | 1 |
| Sun, S; Sun, Y; Wang, S; Yuan, X | 1 |
| Li, SJ; Yang, YZ; Zhang, ZC | 1 |
6 other study(ies) available for astragaloside a and Chronic Disease
| Article | Year |
|---|---|
Evaluation of the effect of Shengxian Decoction on doxorubicin-induced chronic heart failure model rats and a multicomponent comparative pharmacokinetic study after oral administration in normal and model rats.
Topics: Animals; Astragalus propinquus; Cardiovascular Agents; Chromatography, High Pressure Liquid; Chronic Disease; Drugs, Chinese Herbal; Electrocardiography; Heart Failure; Male; Mass Spectrometry; Medicine, Chinese Traditional; Rats; Rats, Sprague-Dawley; Saponins; Triterpenes | 2021 |
Astragaloside IV inhibits ventricular remodeling and improves fatty acid utilization in rats with chronic heart failure.
Topics: Animals; Benzazepines; Chronic Disease; Chymases; Disease Models, Animal; Energy Metabolism; Fatty Acids; Heart Failure; Heart Ventricles; Humans; Myocardium; Myocytes, Cardiac; PPAR alpha; Rats; RNA, Messenger; Saponins; Triterpenes; Ventricular Remodeling | 2018 |
Ameliorating the effect of astragaloside IV on learning and memory deficit after chronic cerebral hypoperfusion in rats.
Topics: Animals; Antioxidants; Apoptosis; Calcium-Binding Proteins; Carotid Artery Diseases; Cerebrovascular Circulation; Chronic Disease; Drug Evaluation, Preclinical; Glial Fibrillary Acidic Protein; Hippocampus; Male; Maze Learning; Microfilament Proteins; Neuroglia; Neuroprotective Agents; Oxidative Stress; Rats, Sprague-Dawley; Saponins; Triterpenes | 2015 |
Inhibitory effects of astragaloside IV on ovalbumin-induced chronic experimental asthma.
Topics: Actins; Allergens; Animals; Anti-Asthmatic Agents; Asthma; Bronchi; Bronchoalveolar Lavage Fluid; Chromatography, High Pressure Liquid; Chronic Disease; Collagen; Cytokines; Female; Fibrosis; Hydroxyproline; Mice; Mice, Inbred BALB C; Mucus; Ovalbumin; Saponins; Th2 Cells; Transforming Growth Factor beta1; Triterpenes | 2008 |
Effects of astragaloside IV on IFN-gamma level and prolonged airway dysfunction in a murine model of chronic asthma.
Topics: Animals; Asthma; Astragalus Plant; Bronchial Hyperreactivity; Bronchoalveolar Lavage Fluid; Chronic Disease; Collagen; Disease Models, Animal; Drugs, Chinese Herbal; Female; Immune System; Inflammation; Interferon-gamma; Mice; Mice, Inbred BALB C; Mucus; Ovalbumin; Phytotherapy; Plant Roots; Respiratory System; Saponins; Triterpenes | 2011 |
[Effect of astragaloside on myocardial fibrosis in chronic myocarditis].
Topics: Animals; Blotting, Western; Chronic Disease; Coxsackievirus Infections; Drugs, Chinese Herbal; Endomyocardial Fibrosis; Male; Matrix Metalloproteinase 13; Matrix Metalloproteinase 14; Mice; Mice, Inbred BALB C; Myocarditis; Random Allocation; Saponins; Transforming Growth Factor beta; Triterpenes | 2007 |